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Complications of Central Venous Catheterization
To the Editor: The results of the randomized 
trial by Parienti et al. (Sept. 24 issue)1 comparing 
insertion sites for central venous catheterization 
will help guide clinicians in their choice of sites. 
We were surprised, however, that the authors did 
not report the number of patients in each insertion-
site group who were receiving positive-pressure 
ventilation. The increased positive end-expiratory 
pressure and large tidal volumes associated with 
mechanical ventilation can predispose a patient to 
the development of pneumothorax. Some evidence 
suggests that the risk of pneumothorax from sub-
clavian-vein catheterization may be higher among 
patients receiving positive-pressure ventilation 
than among those not receiving it.2 Without 
knowing how the outcomes are stratified accord-
ing to ventilation status, it is hard to fairly assess 
the true risk profile of subclavian-vein access.
The authors correctly observe that “the cumu-
lative risk of infectious and thrombotic compli-
cations increases with increasing catheter expo-
sure.” We think the inference is worth stating 
more plainly: one means of preventing infec-
tious complications from central venous cathe-
terization is prompt removal of the catheter when 
it is no longer needed.3
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To the Editor: We are concerned with the re-
porting by Parienti and colleagues of central-
catheter–associated bloodstream infections with 
the use of Medical Dictionary for Regulatory Activities 
definitions. These rates are inconsistent with 
contemporaneous American and Australian data 
on central-catheter–associated bloodstream infec-
tions defined according to the Centers for Dis-
ease Control and Prevention (CDC).1,2
Data from the Victorian Healthcare Asso-
ciated Infection Surveillance System, based on 
303,968 days of central venous catheter use at 29 
intensive care units (ICUs) from 2009 through 
2013, showed the statewide rate of catheter-
associated bloodstream infections to be 1.26 per 
1000 catheter-days.2 This is approximately 60% 
of the aggregate 2.0 bloodstream infections per 
1000 catheter-days reported in the 3SITES trial 
by Parienti et al.
Our institution is a typical Australian tertiary 
referral center. Local protocols for the insertion 
of central venous catheters mandate the follow-
ing: skin preparation with topical chlorhexidine, 
chlorhexidine-impregnated catheters, and ultra-
sonographic guidance.3 The rate of central-
catheter–associated bloodstream infections in 
local ICUs is 1.1 per 1000 catheter-days overall. 
Moreover, the rate of attributable iatrogenic 
pneumothorax in our ICU was 0 per 2221 inser-
tions of central venous catheters from 2013 
through 2015. We suggest that the findings of 
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the 3SITES trial are of limited external validity 
to jurisdictions and sites that apply the above 
catheter-insertion principles and different defini-
tions of central-catheter–associated bloodstream 
infections.
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To the Editor: The 3SITES trial provides site-
specific complication rates after central venous 
catheterization and suggests the preferential use 
of the subclavian vein in critical illness. Not con-
sidered, however, are long-term complications, 
which might influence the choice of site, particu-
larly in the subgroup of patients who are likely to 
require long-term dialysis.
Chronic central-vein stenosis is asymptomatic 
in many persons but leads to malfunction of sur-
gically created arteriovenous fistulae in patients 
receiving dialysis, in whom it often recurs after 
venoplasty. Central-vein stenosis is particularly 
associated with catheters in the subclavian vein 
(as opposed to the internal jugular or femoral 
vein),1,2 regardless of catheter size, even after 
short-term use.3
This is of relevance to a growing proportion 
of patients: between 1996 and 2010, the percent-
age of critically ill patients who initiated dialysis 
during intensive care increased by a factor of 
almost 4, with up to a quarter of surviving pa-
tients remaining permanently dependent on dialy-
sis.4 The subclavian venous site may provide 
short-term benefits, but in those who may face 
permanent renal failure, this site has longer-
term disadvantages that need consideration.
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To the Editor: In the trial reported by Parienti 
and colleagues, the authors conclude that subcla-
vian catheterization was associated with a higher 
risk of pneumothorax than was jugular or femo-
ral catheterization. We believe that this conclu-
sion concerning the pneumothorax rate cannot 
be generalized to other ICUs for a number of rea-
sons: both French and U.S. guidelines recommend 
the use of the ultrasonography-guided technique 
for all sites, but only 15% of the subclavian pro-
cedures in the present trial were performed with 
ultrasonographic guidance1,2; it cannot be ruled 
out that the ultrasonography-guided technique 
was preferentially chosen by operators in patients 
who presented with risk factors for pneumotho-
rax (e.g., obesity or emphysema); and the inci-
dence of pneumothorax in subclavian procedures 
reported here was 1.5%, whereas in studies using 
ultrasonography-guided subclavian procedures, 
the rate was between 0 and 0.2%, similar to the 
pneumothorax rate reported in the jugular site in 
the present trial.3,4 For all these reasons, the au-
thors’ conclusion that subclavian procedures are 
associated with an increased risk of pneumotho-
rax pertains only to physicians using the nonrec-
ommended landmark technique.
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To the Editor: Parienti et al. report catheter-
related infectious and thrombotic complications 
of central venous catheterization according to 
insertion site. They chose compression ultraso-
nography as the diagnostic standard for deep-
vein thrombosis (DVT). Although compression 
ultrasonography alone has efficacy that is simi-
lar to that of combined-method ultrasonography 
(color Doppler ultrasonography combined with 
compression ultrasonography) in diagnosing DVT 
in the legs,1 this might not be the case for DVT in 
the arms. The vascular insertion site of subclavian-
vein catheterization is usually located beneath 
the clavicle, which makes it difficult for the site 
to be visualized or compressed with compression 
ultrasonography. Color Doppler ultrasonography 
has been shown to be more sensitive and accu-
rate than compression ultrasonography in diag-
nosing DVT in the arms.2 The American College 
of Chest Physicians guidelines also suggest ini-
tial evaluation with combined-method ultraso-
nography over other initial tests in patients with 
suspected DVT in the arms.3 Using compression 
ultrasonography alone to diagnose subclavian-
vein thrombosis might lead to underestimation 
of the event rate.
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To the Editor: Parienti et al. report that use of 
the subclavian site for catheter insertion was as-
sociated with lower risks of infection and throm-
bosis but a higher risk of pneumothorax than use 
of the jugular or femoral sites. Although these 
results may be explained by the choice of anatom-
ical site alone, there are other factors of equal or 
greater importance. Rates of ultrasonographic 
guidance for catheter insertion were low, which 
could explain the reported rates of insertion fail-
ure, hematoma, and pneumothorax. Systematic 
reviews show that the use of ultrasonographic 
guidance for central venous cannulation is asso-
ciated with fewer complications than without 
such guidance.1,2 Chlorhexidine skin preparation 
was used less than 50% of the time, and chlorhexi-
dine-impregnated dressings were not used.3 Less 
than 60% of the catheters were removed when no 
longer required. Appropriate indications for cen-
tral-venous-catheter placement, the use of inser-
tion bundles, proper catheter care (including the 
use of chlorhexidine-impregnated dressings),4 
daily needs assessment, and prompt removal of 
catheters when no longer needed may be more 
important than the insertion site.
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The authors reply: Vinson et al. raise the issue 
of ventilation status. The majority of catheteriza-
tions were performed with positive-pressure ven-
tilation (2859 of 3471 [82.4%]) and positive end-
expiratory pressure (PEEP) ventilation (2676 of 
3471 [77.1%]). The higher risk of pneumothorax 
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associated with the use of PEEP than with non-
use is difficult to assess, because the PEEP was 
turned off at the inserter’s discretion during 
catheterization.
In response to Urbancic et al.: we used a rigor-
ous definition of catheter-related bloodstream in-
fection,1 not the less accurate surveillance defi-
nition of central-catheter–associated bloodstream 
infection to which they refer. The former defini-
tion requires specific laboratory testing in order to 
unambiguously identify the catheter as the source 
of the bloodstream infection, whereas the latter 
definition indicates a bloodstream infection that 
occurred in the presence of a central catheter or 
within 48 hours after its removal, without any 
obvious other cause except the catheter. The low 
incidence of central-catheter–associated blood-
stream infection that they report may relate to a 
different case mix or the use of chlorhexidine-
coated catheters, which were not used in our trial. 
Given their low rate of pneumothorax, they could 
decrease further their incidence of central-cathe-
ter–associated bloodstream infection by adding the 
CDC and Australian and New Zealand Intensive 
Care Society guidelines recommendation “prefer 
the subclavian site” to their local protocol.
The risk of subclavian-vein stenosis2 described 
by Corbett and Ashby has been associated with 
dialysis catheters. We excluded these devices.
Maizel and Slama may have misinterpreted 
the guidelines for catheterization3 in the subclavian 
vein, which state, “We suggest that ultrasound 
dynamic guidance is of limited value for most op-
erators to guide subclavian-vein catheterization 
in adult patients (and that landmark technique is 
used instead).” Our multicenter trial reflects cur-
rent real-world practice in France, with ultraso-
nography used at the discretion of the operator.
Keng informs us about the sensitivity of com-
pression ultrasonography to diagnose subclavian 
DVT. The rate of Doppler-defined subclavian DVT 
ranged from 2 cases per 107 catheters (1.9%) to 
8 cases per 123 catheters (6.5%) in previous 
trials,4 and we found a rate of 21 cases per 401 
catheters (5.2%).
We agree with Bauer and colleagues that factors 
other than the insertion site can influence the 
risk of intravascular complications, but the site 
access was randomized. The CDC guidelines 
available when our trial was initiated1 stated, 
“No comparison has been made between using 
chlorhexidine preparations with alcohol and 
povidone–iodine in alcohol to prepare clean skin. 
Unsolved issue.” The results of the CLEAN trial5 
were not available when we initiated or con-
ducted our trial. Nevertheless, the incidence of 
catheter-related bloodstream infections in that 
trial was similar with chlorhexidine prepara-
tions and povidone–iodine preparations (P = 0.51) 
for central venous catheters.
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Pregnancy, Primary Aldosteronism, and Somatic CTNNB1 
Mutations
To the Editor: Teo et al. (Oct. 8 issue)1 describe 
three women with aldosterone-producing adeno-
mas. Each adenoma had a somatic mutation in 
CTNNB1, the gene encoding β-catenin in the Wnt 
cell-differentiation pathway. The authors sug-
gest that there is an association among a somat-
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